WeedLife News Network
Secret DEA Scandal - Marijuana Drug Blockage
WASHINGTON, DC / ACCESS Newswire / June 10, 2025 / The DEA Diversion division cast of clowns needs a summer assignment and MMJ BioPharma Cultivation has a suggestion: go back and read your own mission statement and training manual.
For years, the DEA DEPUTY Administrator has been the face of obstruction inside the DEA's Diversion Control Division, using his signature to delay, deny, and destroy federally compliant scientific research-including the case of MMJ BioPharma Cultivation, which has been blocked from developing pharmaceutical-grade cannabis for over 2,300 days.
But now, documents from the DEA's own internal guidance-Sections 5202.5 and 5201.12 of the Diversion Control Manual-expose a truth that Prevoznik either doesn't understand or is deliberately ignoring:
The DEA is required to support bona fide Schedule I research, expedite applications, and allow legitimate brokers to process international shipments without registering as importers.
Copyright
©420 Intel
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
